BJPsych Bulletin (2018) Page 1 of 4, doi:10.1192/bjb.2017.34
Dipen Patel,1 Manjunath Minajagi, 1Leicestershire Partnership NHS Trust, Leicester, UK, Dipen Patel (firstname.lastname@example.org)
|Primary diagnosis||% admission|
|Bipolar affective disorder||17.3|
|Acute or unspecified psychotic disorder||6.7|
|Psychoactive substance-related disorders||6.7|
91% had < 20 ng of vitamin D
Note: Probably almost all admissions had <30 ng
- 99 percent of psychiatric population had less than 30 ng of vitamin D – June 2013
- Mental health problems cut in half when have adequate level of vitamin D – Jan 2013
- Omega-3 and Vitamin D each treat many mental health problems - April 2018 has the following summary
|Mental Illnesses list |
of National Alliance of MI
# of items
|Borderline Personality Disorder||7|
|Early Psychosis and Psychosis||296|
|Posttraumatic Stress Disorder||30|
Aims and method Vitamin D deficiency is increasing in the general population, and is linked with physical and mental illness. However, evidence on its prevalence in people with mental illness is limited. This study investigated vitamin D deficiency in 104 adult patients admitted to a psychiatric hospital in the UK.
Results Forty-nine per cent were vitamin D deficient (serum 25(OH)D <30 nmol/L), and a further 42.3% were vitamin D insufficient (<50 nmol/L). On admission, 8.7% of patients were vitamin D sufficient (>50 nmol/L). There were no statistically significant differences in mean serum vitamin D between different subgroups of mental illness.
Clinical implications Vitamin D deficiency is highly prevalent among individuals with severe mental illness admitted to hospital. Assessment and treatment of vitamin D deficiency should be considered in in-patients to protect musculoskeletal health. Further epidemiological and intervention studies are needed to investigate the role of vitamin D in the pathophysiology of mental disorders.